Sanofi's CDMO spinoff set for next month as new group targets 2022 revenues of €1B

When Sanofi unveiled plans to spin off its European active pharmaceutical ingredient (API) unit back in early 2020, the world looked quite different. But more than two years and a global pandemic later, Sanofi is nearing the end of the spinoff process.